Showing 1701-1710 of 2813 results for "".
- Eucerin Introduces First Face Care Collection With Multi-Weight Hyaluronic Acid Technologyhttps://modernaesthetics.com/news/eucerin-introduces-first-face-care-collection-with-multi-weight-hyaluronic-acid-technology/2473544/Hitting shelves January 2024, Eucerin's Immersive Hydration Collection is a new entry into the face-care category with a unique, multi-weight hyaluronic acid formulation. A first to pioneer this technology across a full face care regimen* to intensively hydrate skin and visibly smoo
- 5 Things We Can’t Wait to See at the 2024 Octane Aesthetics Tech Forumhttps://modernaesthetics.com/news/5-things-we-cant-wait-to-see-at-octane-aesthetics-tech-forum-2024/2473543/In a world where technology, artistry, and business are increasingly intersecting, the Octane Aesthetics Tech Forum 2024 running January 25 – 26 in Newport Beach, CA is rapidly becoming a “must” for anyone working in the field. Under the theme 'Forging the Future of Aestheti
- AestheticWires’s Toxin Pipeline Watch: RelabotulinumtoxinA Smoothes Crow’s Feet and Frown Lines Quickly and Results Last in Phase IIIb Studieshttps://modernaesthetics.com/news/aestheticwiress-toxin-pipeline-watch-relabotulinumtoxina-smoothes-crows-feet-and-frown-lines-quickly-and-results-last-in-phase-iiib-studies/2473537/RelabotulinumtoxinA produces rapid and long-lasting effects on crow’s feet and frown kines, according to topline results from two phase IIIb studies. Galderma’s relabotulinumtoxinA is a novel liquid formulation of botulinum toxin A currently being investigated globally.
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- Amogh Kothare Is Advalight’s New Chief Scientific Officerhttps://modernaesthetics.com/news/amogh-kothare-is-advalights-new-chief-scientific-officer/2473532/Amogh Kothare is the new Chief Scientific Officer of Advalight. In this role, Mr. Kothare will be responsible for clinical research, partnerships, product management, and clinical affairs and training to further leverage the brand. A "Under Amogh's sci
- Allergan Aesthetics and The Black Beauty Club Partner to Foster Diversity in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-x-the-black-beauty-club-partner-to-advance-diversity-in-aesthetics/2473531/Allergan Aesthetics joined forces with the Black Beauty Club for a consumer initiative to spark open dialogue and empower Black individuals to embrace their unique beauty and make informed decisions about their aesthetic care. The event, which took place in Atlanta on Novembe
- Aesthetic Trend Spotting With New York City Facial Plastic Surgeon Dr. Jennifer Levinehttps://modernaesthetics.com/news/aesthetic-trend-spotting-with-new-york-city-facial-plastic-surgeon-dr-jennifer-levine/2473529/Regenerative aesthetics and other novel treatments are changing the way that doctors and patients think about and approach facial aging. New York City facial plastic surgeon Jennifer Levine, MD, spoke to AestheticsWire about regenerative aesthetics and other hot trends during
- Avéli Cellulite Device Cleared in Australiahttps://modernaesthetics.com/news/aveli-cellulite-device-cleared-in-australia/2473527/Revelle Aesthetics’ Avéli is now cleared for long-term reduction in the appearance of cellulite in Austr
- Study: Lumenato Boosts Skin Barrier Function, Collagen and Ceramideshttps://modernaesthetics.com/news/study-lumenato-boosts-skin-barrier-function-collagen-and-ceramides/2473526/Lycored's Lumenato may improve the skin barrier function and boost collagen and ceramides after 12 weeks of daily supple
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo